AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 100818
Drug: Intravenous methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous methylphenidate (0.5 mg/kg)
Trial: 15893916
Drug: Daily chlorpromazine-equivalent
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily chlorpromazine-equivalent dose of antipsychotics
Trial: 9583339
Drug: Diet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet treatment (DT)
Trial: 9583339
Drug: Nondiet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nondiet treatment (NDT)
Trial: 9583339
Drug: Diet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet treatment (DT) and Nondiet treatment (NDT)
Trial: 6240831
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg celiprolol HCl + 25 mg chlorthalidone
Trial: 6240831
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg atenolol + 25 mg chlorthalidone
Trial: 25278405
Drug: 24-hour reports
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour reports filled out by nurses daily
Trial: 15881487
Drug: lumiracoxib 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lumiracoxib 50 mg, 100 mg, 200 mg bid, 400 mg od
Trial: 15881487
Drug: diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac 75 mg bid
Trial: 15881487
Drug: lumiracoxib 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lumiracoxib 100 mg bid, 200 mg bid, 400 mg od
Trial: 15881487
Drug: lumiracoxib 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lumiracoxib 100 mg, 400 mg
Trial: 15881487
Drug: lumiracoxib 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lumiracoxib 400 mg
Trial: 15881487
Drug: ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen 400 mg
Trial: 11870017
Drug: D-cycloserine, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-cycloserine, 50 mg/day
Trial: 8509235
Drug: Tramadol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (100 mg/2 ml vials, 3 vials a day for 3 days)
Trial: 8509235
Drug: Nisidin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisidin (2 ml vials, 3 vials a day for 3 days)
Trial: 2949588
Drug: PN 200‐110
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PN 200‐110 (isradipine) 15 mg
Trial: 19954773
Drug: Cost treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost treatment condition
Trial: 19954773
Drug: Probability treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probability treatment condition
Trial: 15694232
Drug: haloperidol 15
RxNorm normalized name: haloperidol 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol 15 mg/day plus allopurinol 300 mg/day
Trial: 14499318
Drug: haloperidol 15
RxNorm normalized name: haloperidol 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol 15 mg/day plus placebo
Trial: 27138798
Drug: Escitalopram, Sertraline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram, Sertraline, or Venlafaxine (8 weeks treatment, dosage adjusted by clinician)
Trial: 27138798
Drug: Sertraline (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (8 weeks treatment, dosage adjusted by clinician)
Trial: 22541248
Drug: pitrakinra (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pitrakinra (1, 3, or 10 mg twice daily)
Trial: 19850637
Drug: sorafenib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sorafenib (400 mg b.i.d.)
Trial: 18630549
Drug: Integrated Chinese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Chinese and western medicine group
Trial: 18630549
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine (TCM) group
Trial: 12238266
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg cis-atracurium (group C)
Trial: 2140251
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 75 mg dipyridamole with 330 mg acetylsalicylic acid (ASA) tid (high dose)
Trial: 2140251
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 75 mg dipyridamole with 100 mg acetylsalicylic acid (ASA) tid (low dose)
Trial: 66425
Drug: H2-receptor antagonists
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-receptor antagonists (metiamide and cimetidine)
Trial: 66425
Drug: Control (antacids)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (antacids)
Trial: 28298396
Drug: Dairy group
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dairy group (low-fat milk or yogurt servings providing ≥1200 mg Ca/d)
Trial: 28298396
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (usual diet of ≤600 mg Ca/d)
Trial: 25577134
Drug: XELOXIRI/bevacizumab regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XELOXIRI/bevacizumab regimen (oxaliplatin 100 mg/m², capecitabine 1,700 mg/m²/day, irinotecan 150 mg/m², bevacizumab 7.5 mg/kg)
Trial: 19949772
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg/week for 3 months
Trial: 19949772
Drug: Combined therapy:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy: Alendronate 70 mg/week, vitamin D 2800 IU/week, and calcium 1 g/day for 12 months
Trial: 19949772
Drug: Calcium 1
RxNorm normalized name: Calcium 10-undecenoate
DrugBank: Calcium undecylenate (DB15678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 1 g/day and vitamin D 800 IU/day
Trial: 8905958
Drug: Gas barrier
RxNorm normalized name: Valiant Barrier
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gas barrier type tube (group G, n = 11)
Trial: 6604680
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplements (500 mg/day i.m. for 1 month)
Trial: 25276736
Drug: Aloe vera
RxNorm normalized name: ALOE VERA
DrugBank: Aloe vera leaf (DB13906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe vera and Calendula Ointment every 8 hours for 5 days
Trial: 18219235
Drug: Modafinil (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (up to 400 mg)
Trial: 8857856
Drug: High-dose adenosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose adenosine cardioplegia
Trial: 2000739
Drug: Thrombolytic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic and antithrombotic treatment (streptokinase initiated late, heparin infusion for at least 5 days, warfarin and dipyridamole for at least 3 months)
Trial: 6391075
Drug: Naproxen (prostaglandin-inhibitor)
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen (prostaglandin-inhibitor)
Trial: 12067837
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion alone
Trial: 22236501
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitors (PPIs) - omeprazole; n:19
Trial: 22236501
Drug: Histamine H(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine H(2) -receptor antagonists (H(2) RAs) - ranitidine; n:16
Trial: 22236501
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitors (PPIs) - omeprazole; n:11 (previously H(2) RA nonresponders)
Trial: 22236501
Drug: Histamine H(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine H(2) -receptor antagonists (H(2) RAs) - ranitidine; n:1 (previously H(2) RA nonresponder)
Trial: 21199406
Drug: Active agent
RxNorm normalized name: Capillary active agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active agent
Trial: 18053382
Drug: Self-administered medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered medication (SAM)
Trial: 18053382
Drug: Standard administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard administration by nurses
Trial: 14680716
Drug: Alprazolam and
RxNorm normalized name: Alprazolam and propranolol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam and imipramine (placebo-controlled drug trial)
Trial: 10386282
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of droperidol 1.25 mg
Trial: 10386282
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of droperidol 1.25 mg
Trial: 10386282
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of droperidol 1.25 mg and ondansetron 4 mg in combination
Trial: 10386282
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of droperidol 1.25 mg and ondansetron 4 mg in combination
Trial: 2011945
Drug: Oral cyclosporin‐A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclosporin‐A (CyA) at 7.5 mg/kg
Trial: 2011945
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (decreasing doses from 0.8 mg/kg)
Trial: 6123079
Drug: At-home family
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: At-home family therapy
Trial: 23063389
Drug: Intraosseous anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraosseous anesthesia using Quicksleeper (IO injection)
Trial: 15826314
Drug: Beclomethasone Dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone Dipropionate (QVAR) 100 mcg 2 puffs 2 times a day for 6 weeks
Trial: 9797484
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (750 mg/day calcium and 400 IU/day vitamin D)
Trial: 11397884
Drug: Raloxifene (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (both doses)
Trial: 2715372
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of cefotetan (1 g)
Trial: 2715372
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of cefotetan (1 g)
Trial: 318916
Drug: Intravenous loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous loading course of 5-fluorouracil
Trial: 318916
Drug: Weekly intravenous
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly intravenous schedule of 5-fluorouracil
Trial: 318916
Drug: Oral schedule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral schedule of 5-fluorouracil
Trial: 30431171
Drug: Fractional CO2
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional CO2 laser combined with topical TXA
Trial: 30431171
Drug: Fractional CO2
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional CO2 laser combined with intradermal TXA
Trial: 25892016
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment with 1.25 mg intravitreal bevacizumab every 12 weeks after loading doses
Trial: 25892016
Drug: As-needed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: As-needed treatment with 1.25 mg intravitreal bevacizumab every 12 weeks after loading doses
Trial: 24098469
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (4 x 5 g/d for 5 days followed by 5 g/d)
Trial: 24098469
Drug: Placebo (dextrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (dextrose at the same dosage)
Trial: 22016254
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (CEEs; 0.625 mg/day)
Trial: 20034232
Drug: N-acetylcysteine (NAC,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC, 1.8 g/day, 3 days)
Trial: 20034232
Drug: alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-lipoic acid (ALA, 1.2 g/day, 3 days)
Trial: 20034232
Drug: taurine (TAU,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: taurine (TAU, 3 g/day, 3 days)
Trial: 9358198
Drug: Meropenem administered
RxNorm normalized name: Meropenem
DrugBank: Meropenem (DB00760)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meropenem administered by injection over 2 minutes
Trial: 9358198
Drug: Meropenem administered
RxNorm normalized name: Meropenem
DrugBank: Meropenem (DB00760)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meropenem administered by injection over 3 minutes
Trial: 9358198
Drug: Meropenem administered
RxNorm normalized name: Meropenem
DrugBank: Meropenem (DB00760)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meropenem administered by injection over 5 minutes
Trial: 8205299
Drug: Spirapril 6
RxNorm normalized name: spirapril 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 6 mg with isradipine 5 mg
Trial: 28002359
Drug: MenACWY‐TT coadministered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MenACWY‐TT coadministered with routine childhood vaccines
Trial: 28002359
Drug: MenACWY‐TT coadministered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MenACWY‐TT coadministered with childhood vaccines
Trial: 25815491
Drug: Regular inhalation
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular inhalation of salmeterol/fluticasone propionate (SM/FP)
Trial: 25815491
Drug: Intermittent inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent inhalation of salmeterol/fluticasone propionate (SM/FP)
Trial: 23490288
Drug: LOS +
RxNorm normalized name: Losartan
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LOS + HCTZ (losartan 50 mg/d + hydrochlorothiazide 12.5 mg/d)
Trial: 23490288
Drug: LOS +
RxNorm normalized name: Losartan
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LOS + CCB (losartan 50 mg/d + amlodipine 5 mg/d)
Trial: 17698328
Drug: Atomoxetine (max.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (max. 1.8 mg/kg/d)
Trial: 15309547
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg) and alpha-tocopherol (1,200 IU) daily for 37 days
Trial: 11145854
Drug: Interferon gamma
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon gamma therapy
Trial: 11145854
Drug: Thymopentin therapy
RxNorm normalized name: thymopentin
DrugBank: Thymopentin (DB11996)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymopentin therapy
Trial: 9302748
Drug: Bivalent live
RxNorm normalized name: fecal microbiota, live Enema [Rebyota]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent live attenuated influenza A vaccine (10^6 TCID50)
Trial: 10960435
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (endoscopic variceal ligation, nadolol, and sucralfate)
Trial: 8822220
Drug: Mechanical ventilation
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical ventilation with hyperoxic gas mixtures at fixed frequency and tidal volume (twice resting ventilation)
Trial: 27114197
Drug: Tadalafil once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil once-daily (OAD)
Trial: 27114197
Drug: Tadalafil 10
RxNorm normalized name: tadalafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 10 mg (low dose) PRN
Trial: 27114197
Drug: Tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20 mg (high dose) PRN
Trial: 27114197
Drug: Tadalafil 2.5
RxNorm normalized name: tadalafil 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 2.5 mg (low dose) OAD
Trial: 27114197
Drug: Tadalafil 5
RxNorm normalized name: tadalafil 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 5 mg (high dose) OAD
Trial: 22569995
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (500 mg aspirin and 300 mg clopidogrel before intervention, followed by 100 mg aspirin and 75 mg clopidogrel daily for 6 months)
Trial: 22569995
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (500 mg aspirin before intervention, followed by placebo instead of clopidogrel)
Trial: 15914526
Drug: Nandrolone (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nandrolone (150 mg IM biweekly)
Trial: 20974577
Drug: Testosterone (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (250 mg IM biweekly)
Trial: 8758241
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PSA (> 10 micrograms/l) and DRE
Trial: 24468257
Drug: rhC1INH (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhC1INH (50 IU/kg to maximum 4,200 IU/treatment)
Trial: 22834291
Drug: Infusion therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion therapy with remaxol (800 ml/day)
Trial: 22834291
Drug: Infusion therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion therapy with sterofundine-G-5
Trial: 22834291
Drug: Infusion therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion therapy with ringer's lactate and 10% glucose solution (1:1)
Trial: 22834291
Drug: Infusion therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion therapy with remaxol
Trial: 1378382
Drug: Methohexital 0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methohexital 0.7 mg/kg
Trial: 1378382
Drug: Methohexital 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methohexital 1.5 mg/kg
Trial: 6543314
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) 80 mg single dose
Trial: 6543314
Drug: Isosorbide 5‐mononitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide 5‐mononitrate (IS‐5‐MN) 80 mg single dose
Trial: 31195354
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with cetuximab (anti-EGFR-directed monoclonal antibody) in combination with capecitabine and cisplatin
Trial: 31195354
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with capecitabine and cisplatin
Trial: 29370022
Drug: Latanoprost 0.005%
RxNorm normalized name: LATANOPROST 0.005% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost 0.005% ophthalmic solution
Trial: 24456698
Drug: BMC+Phone (BMC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMC+Phone (BMC plus monthly phone calls by a Community Health Worker)
Trial: 24456698
Drug: BMC+Home (BMC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMC+Home (BMC plus monthly home visits by a Community Health Worker)
Trial: 21803976
Drug: NaClO(3) 60
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaClO(3) 60 mg·kg of BW(‐1)
Trial: 21803976
Drug: NaClO(3) 90
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaClO(3) 90 mg·kg of BW(‐1)
Trial: 21803976
Drug: NaClO(3) 150
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaClO(3) 150 mg·kg of BW(‐1)
Trial: 21803976
Drug: NaClO(3) 300
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaClO(3) 300 mg·kg of BW(‐1)
Trial: 21803976
Drug: NaClO(3) 450
RxNorm normalized name: glucose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaClO(3) 450 mg·kg of BW(‐1)
Trial: 21803976
Drug: Control (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (saline NaCl, 30 mg·kg of BW(‐1) for lambs; 150 mg·kg of BW(‐1) for ewes)